Geneos Wealth Management’s Hartford Multifactor Developed Markets ex-US ETF RODM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-254
Closed -$8.66K 3040
2025
Q2
$8.66K Hold
254
﹤0.01% 2375
2025
Q1
$15.7K Buy
+254
New +$7.62K ﹤0.01% 2426
2024
Q3
Sell
-142
Closed -$3.92K 2609
2024
Q2
$3.92K Hold
142
﹤0.01% 1770
2024
Q1
$3.98K Buy
+142
New +$3.88K ﹤0.01% 1758
2021
Q2
Sell
-21,562
Closed -$656K 3066
2021
Q1
$656K Buy
+21,562
New +$628K 0.02% 561

Other funds holding RODM

Geneos Wealth Management's RODM Position: Q3 2025 in Review

Geneos Wealth Management sold out of Hartford Multifactor Developed Markets ex-US ETF (RODM) in Q3 2025, closing a stake of 254 shares — an estimated $8.66K sold.

Geneos Wealth Management first reported a position in RODM in Q1 2021 and held it in 5 quarters. The position peaked at $656K in Q1 2021. 115 funds tracked by Wall St. Rank hold RODM as of Q3 2025.

  • Geneos Wealth Management reported no remaining Hartford Multifactor Developed Markets ex-US ETF position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 254 Hartford Multifactor Developed Markets ex-US ETF shares in Q3 2025, an estimated $8.66K.
  • Geneos Wealth Management first reported a position in Hartford Multifactor Developed Markets ex-US ETF in Q1 2021 and held it in 5 quarters.
  • Geneos Wealth Management's Hartford Multifactor Developed Markets ex-US ETF position peaked at $656K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Hartford Multifactor Developed Markets ex-US ETF as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.